Quell Therapeutics to Present at the 2021 Wedbush Pacgrow Healthcare Virtual Conference

LONDON and BOSTON, Aug. 4, 2021 /PRNewswire/ — Quell Therapeutics Ltd (“Quell”), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that Iain McGill, Chief Executive Officer of Quell…

About the Author

has written 39363 stories on this site.

Copyright © 2010 Business and Corporate News.